Home › Valeant reports stronger Q1 results, issues bullish outlook for Q2 and 2015
 

Keywords :   


Valeant reports stronger Q1 results, issues bullish outlook for Q2 and 2015

2015-04-29 20:49:15| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. has issued first quarter results that beat analyst estimates and boosted its 2015 estimates to account for about US$1 billion of additional revenue from Salix Pharmaceuticals. The Quebec-based company conducted a bidding war for Salix during the first quarter and closed the US$11.1-billion deal on April 1, which marked the beginning of its second quarter.

Tags: results issues reports outlook

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »